| 治疗糖尿病创新药物研究 |
| |
| 引用本文： | 崔秋兵,赵启鹏,张艺.治疗糖尿病创新药物研究[J].医学与哲学,2009,30(2):58-59. |
| |
| 作者姓名： | 崔秋兵 赵启鹏 张艺 |
| |
| 作者单位： | 成都中医药大学,四川成都611137 |
| |
| 摘 要： | 本论文从治疗2型糖尿病药物应用现状出发，通过对2型糖尿病病理的认识，新发现的主要受体和相关药靶等方面进行分析。指出随着对糖尿病认识的深入发展，治疗糖尿病创新药物研究的发展趋势也发生了相应的变化，就是从局部治疗到全身综合考虑，从药物外部直接地干预到增强自身调节功能。为治疗2-型糖尿病药物发展指明了方向。
|
| 关 键 词： | 2型糖尿病 受体 药靶 活性先导化合物 |
New Drug Study in Curing Type 2- Diabetes Mellitus |
| |
| CUI Qiu-bing,ZHAO Qi-peng,ZHANG Yi.New Drug Study in Curing Type 2- Diabetes Mellitus[J].Medicine & Philosophy:Humanistic & Social Medicine Edition,2009,30(2):58-59. |
| |
| Authors: | CUI Qiu-bing ZHAO Qi-peng ZHANG Yi |
| |
| Institution: | (Chengdu University of TCM,Chengdu 611137 ,China) |
| |
| Abstract: | Starting from the treatment of drug in curing type 2-diabetes mellitus（DM-2） now, this essay mainly analyzes the pathogenesis of DM-2, the receptors and targets in curing DM-2. Following the deep recognition of DM-2, the develop tendency of new drug study in curring DM-2 changes corresponding. That is treatment from part to all over the body,new drug from direct intervention to enhance self regulation function. From these , the develop tendency and direction of new drug study in curring DM-2 are pointed out. |
| |
| Keywords: | type 2-diabetes mellitus receptor target active lead compound |
| 本文献已被 维普 等数据库收录！ |
|
